2 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Peter Vestergaard: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment of Primary Hyperparathyroidism With Denosumab and Cinacalcet. Cinacalcet 30 mg Tablet, Denosumab Inj 60 mg/ml, Placebo tablets - Primary Hyperparathyroidism, Parathyroid Adenoma | Phase 3 | Completed | Peter Vestergaard | 46 | 2017-03-01 | 2021-05-25 |
| CGM Precision and Glycaemic Variability CGM - Diabetes Type 1 | Completed | Peter Vestergaard | 472 | 2016-06-06 | 2019-11-20 |
Diabetes Mellitus, Type 1 (1) · Hyperparathyroidism, Primary (1) · Parathyroid Neoplasms (1)
Cinacalcet (1) · Denosumab (1) · Sodium Chloride (1) · Tablets (1)
Denmark (1)
2016 (1)